The Lack of Ad Hoc Neuropsychological Assessment in Adults with Neurofibromatosis: A Systematic Review

被引:0
作者
Maresca, Giuseppa [1 ]
Bonanno, Carmen [1 ]
Veneziani, Isabella [2 ]
Buono, Viviana Lo [1 ]
Latella, Desiree [1 ]
Quartarone, Angelo [1 ]
Marino, Silvia [1 ]
Formica, Caterina [1 ]
机构
[1] IRCCS Ctr Neurolesi Bonino Pulejo, SS 113 Via Palermo, I-98124 Messina, Italy
[2] Univ Pavia, Dept Nervous Syst & Behav Sci, Psychol Sect, Piazza Botta 11, I-27100 Pavia, Italy
关键词
neurofibromatosis Type 1; neuropsychological assessment; cognitive impairment; neurorehabilitation; visuospatial functions; executive functions; NERVE SHEATH TUMORS; COGNITIVE DEFICITS; TYPE-1; CHILDREN; ATTENTION; T2-HYPERINTENSITIES; ADOLESCENTS; ORIGIN; MOTOR; NF1;
D O I
10.3390/jcm13051432
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Neurofibromatosis Type 1 (NF1) is a genetic autosomal dominant disorder that affects both the central and peripheral nervous systems. Children and adolescents with NF1 commonly experience neuropsychological, motor, and behavioral deficits. The cognitive profile hallmark of this disorder includes visuospatial and executive function impairments. These cognitive disorders may persist into adulthood. This study aims to analyze previous research studies that have described cognitive dysfunctions in adults with NF1. The purpose of this analysis is to review the neuropsychological and psychological assessment methods used. Methods: A total of 327 articles were identified based on the search terms in their titles and abstracts. The evaluation was conducted by scrutinizing each article's title, abstract, and text. Results: Only 16 articles were found to be eligible for inclusion based on the pre-defined criteria. The selected studies primarily focus on the development of diagnostic protocols for individuals with NF1. Conclusions: The management of NF1 disease requires a multidisciplinary approach to address symptoms, preserve neurological functions, and ensure the best possible quality of life. However, cognitive impairment can negatively affect psychological well-being. This study suggested that cognitive functions in NF1 patients were not tested using specific measures, but rather were evaluated through intelligence scales. Additionally, the findings revealed that there is no standardized neuropsychological assessment for adults with NF1. To address this gap, it would be helpful to create a specific neuropsychological battery to study cognitive function in NF1 patients during clinical studies. This battery could also serve as a tool to design models for cognitive rehabilitation by using reliable and sensitive measures of cognitive outcomes.
引用
收藏
页数:12
相关论文
共 46 条
  • [1] Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review
    Baudou, Eloise
    Nemmi, Federico
    Biotteau, Maelle
    Maziero, Stephanie
    Peran, Patrice
    Chaix, Yves
    [J]. FRONTIERS IN NEUROLOGY, 2020, 10
  • [2] A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I
    Bearden, Carrie E.
    Hellemann, Gerhard S.
    Rosser, Tena
    Montojo, Caroline
    Jonas, Rachel
    Enrique, Nicole
    Pacheco, Laura
    Hussain, Shaun A.
    Wu, Joyce Y.
    Ho, Jennifer S.
    McGough, James J.
    Sugar, Catherine A.
    Silva, Alcino J.
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (04): : 266 - 279
  • [3] Systematic Review and Meta-analysis of Executive Functions in Preschool and School-Age Children With Neurofibromatosis Type 1
    Beaussart, Marie-Laure
    Barbarot, Sebastien
    Mauger, Claire
    Roy, Arnaud
    [J]. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2018, 24 (09) : 977 - 994
  • [4] How Does the Schwann Cell Lineage Form Tumors in NF1?
    Carroll, Steven L.
    Ratner, Nancy
    [J]. GLIA, 2008, 56 (14) : 1590 - 1605
  • [5] Relationship between cognitive dysfunction, gait, and motor impairment in children and adolescents with neurofibromatosis type 1
    Champion, Joel A.
    Rose, Kristy J.
    Payne, Jonathan M.
    Burns, Joshua
    North, Kathryn N.
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2014, 56 (05) : 468 - 474
  • [6] Delineating the autistic phenotype in children with neurofibromatosis type 1
    Chisholm, Anita K.
    Haebich, Kristina M.
    Pride, Natalie A.
    Walsh, Karin S.
    Lami, Francesca
    Ure, Alex
    Maloof, Tiba
    Brignell, Amanda
    Rouel, Melissa
    Granader, Yael
    Maier, Alice
    Barton, Belinda
    Darke, Hayley
    Dabscheck, Gabriel
    Anderson, Vicki A.
    Williams, Katrina
    North, Kathryn N.
    Payne, Jonathan M.
    [J]. MOLECULAR AUTISM, 2022, 13 (01)
  • [7] Neuropsychological impairments in elderly Neurofibromatosis type 1 patients
    Costa, Danielle de Souza
    de Paula, Jonas Jardim
    de Rezende, Nilton Alves
    Carneiro Rodrigues, Luiz Oswaldo
    Malloy-Diniz, Leandro Fernandes
    Romano-Silva, Marco Aurelio
    de Miranda, Debora Marques
    [J]. EUROPEAN JOURNAL OF MEDICAL GENETICS, 2014, 57 (05) : 216 - 219
  • [8] Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group
    Descheemaeker, M. -J.
    Plasschaert, E.
    Frijns, J. -P.
    Legius, E.
    [J]. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2013, 57 (09) : 874 - 886
  • [9] Cohort profile: life with neurofibromatosis 1-the Danish NF1 cohort
    Doser, Karoline
    Hove, Hanne
    Ostergaard, John R.
    Bidstrup, Pernille E.
    Dalton, Susanne O.
    Handrup, Mette Moller
    Ejerskov, Cecilie
    Kroyer, Anja
    Doherty, Mia Aagaard
    Jepsen, Jens Richardt Mollegaard
    Mulvihill, John J.
    Winther, Jeanette F.
    Kenborg, Line
    [J]. BMJ OPEN, 2022, 12 (09):
  • [10] Multivariate Pattern Analysis Reveals Subtle Brain Anomalies Relevant to the Cognitive Phenotype in Neurofibromatosis Type 1
    Duarte, Joao V.
    Ribeiro, Maria J.
    Violante, Ines R.
    Cunha, Gil
    Silva, Eduardo
    Castelo-Branco, Miguel
    [J]. HUMAN BRAIN MAPPING, 2014, 35 (01) : 89 - 106